The court order, in a lawsuit by the state of Louisiana, pauses a Food and Drug Administration regulation that greatly expanded access to the abortion pill mifepristone. [TheTopNews] Read More.
THE NEW YORK TIMES – Health | Consumers & ShoppingFri, May 1, 2026